Nektar Therapeutics (NKTR)

$ 0.61
   
  • Change Today:
    $-0.03
  • 52 Week High: $1.83
  • 52 Week Low: $0.49
  • Currency: US Dollars
  • Shares Issued: 180.09m
  • Volume: 2,262,197
  • Market Cap: $109.28m
  • RiskGrade: 333

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-20 31-Dec-19 31-Dec-18
Continuing Operations      
Revenue 152.91 114.62 1,193.32
Operating Profit/(Loss) (425.11) (440.04) 687.93
Profit Before Tax (443.95) (440.05) 682.72
Profit After Tax (444.44) (440.67) 681.31
       
Earnings per Share - Basic (249.00¢) (252.00¢) 402.00¢
Earnings per Share - Adjusted (249.00¢) (252.00¢) 402.00¢
       
Dividend per Share n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-20 31-Dec-19 31-Dec-18
Assets      
Non-Current Assets      
Property, Plant & Equipment 186.14 199.84 48.85
Intangible Assets 76.50 76.50 76.50
Other Non-Current Assets 138.12 279.46 587.13
  400.76 555.81 712.48
Current Assets      
Inventories 15.29 12.66 11.38
Cash at Bank & in Hand 198.96 96.36 194.90
Other Current Assets 923.76 1,312.52 1,231.40
  1,138.00 1,421.55 1,437.69
       
Other Assets n/a n/a n/a
Total Assets 1,538.77 1,977.36 2,150.17
Current Liabilities      
Borrowings 13.91 265.41 n/a
Other Current Liabilities 101.86 88.49 82.00
       
Current Liabilities 115.78 353.89 82.00
       
Net Current Assets c1,022.23 c1,067.66 c1,355.69
       
Borrowings 136.37 142.73 246.95
Other Non-Current Liabilities 209.32 75.34 103.64
Non-Current Liabilities 345.69 218.07 350.59
       
Other Liabilities n/a n/a n/a
Total Liabilities 461.47 571.97 432.60
       
Net Assets 1,077.30 1,405.39 1,717.57
       
Shareholders Funds 1,077.30 1,405.39 1,717.57
       
Minority Interests/Other Equity n/a n/a n/a
Total Equity 1,077.30 1,405.39 1,717.57
Cash Flow 31-Dec-20 31-Dec-19 31-Dec-18
Net Cash Flow From Operating Activities (313.29) (328.68) 718.21
Net Cash Flow from Investing Activities 496.21 206.89 (1,379.94)
Net Cash Flow from Financing Activities (80.33) 23.25 851.86
Net Increase/Decrease In Cash 102.59 (98.54) 190.14
Ratios - based on IFRS 31-Dec-20 31-Dec-19 31-Dec-18
Continuing Operations      
PE Ratio - Adjusted n/a n/a 8.2
PEG - Adjusted n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a
Dividend Cover n/a n/a n/a
Revenue per Share 84.91¢ 63.64¢ 662.62¢
Pre-Tax Profit per Share (246.51¢) (244.35¢) 379.10¢
Operating Margin (278.00%) (383.92%) 57.65%
Return on Capital Employed n/a n/a 36.16%
       
Dividend Yield 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a
Operating Cash Flow per Share (173.96¢) (182.51¢) n/a
Cash Incr/Decr per Share 56.97¢ (54.72¢) 105.58¢
Net Asset Value per Share (exc. Intangibles) 555.72¢ 737.90¢ 911.25¢
Net Gearing -4.52% 22.18% 3.03%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page